Terpenes

Aromatic constituents of cannabis and many other plants. They are not a measure of THC or CBD content, and they are not a substitute for checking cannabinoid–drug interactions.

What they are

Terpenes are volatile plant constituents that account for much of the characteristic aroma of a product (for example citrus, pine, lavender, hops, pepper). A prominent aroma does not imply a high cannabinoid dose. Concentration, not smell, determines exposure.

Entourage effect

It is often suggested that terpenes modify the clinical effect of THC and CBD. Human evidence is limited. Patient preference for an aroma is not a reliable marker of interaction risk.

Drug–terpene interaction

A small number of 2016–2026 studies have tested individual terpenes against drug-metabolising enzymes or transporters. Most work is in vitro. Clinical significance is not established.

Limit of these notes

Treat “possible metabolic overlap” as a reason to read the primary paper and the product information — not as a demonstrated in-vivo interaction. Human evidence that terpenes modify THC or CBD effect remains limited. A smell is not an interaction, and aroma is not a proxy for interaction risk.

Sources on this page4

A searchable constituent monograph — practice point, implications, and evidence grading — is available after sign-in. It is not a second interaction checker.

Educational information only. It is not a diagnosis, prescription, or a substitute for advice from a registered health practitioner.